These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19063686)

  • 1. PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation.
    Theman TA; Collins MT; Dempster DW; Zhou H; Reynolds JC; Brahim JS; Roschger P; Klaushofer K; Winer KK
    J Bone Miner Res; 2009 May; 24(5):964-73. PubMed ID: 19063686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Matrix Mineralization in Patients With Gain-of-Function Calcium-Sensing Receptor Mutations Is Distinctly Different From that in Postsurgical Hypoparathyroidism.
    Ovejero D; Misof BM; Gafni RI; Dempster D; Zhou H; Klaushofer K; Collins MT; Roschger P
    J Bone Miner Res; 2019 Apr; 34(4):661-668. PubMed ID: 30496603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).
    Dong B; Endo I; Ohnishi Y; Kondo T; Hasegawa T; Amizuka N; Kiyonari H; Shioi G; Abe M; Fukumoto S; Matsumoto T
    J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
    Winer KK; Kelly A; Johns A; Zhang B; Dowdy K; Kim L; Reynolds JC; Albert PS; Cutler GB
    J Pediatr; 2018 Dec; 203():391-399.e1. PubMed ID: 30470382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of parathyroid hormone administration in a patient with severe hypoparathyroidism caused by gain-of-function mutation of calcium-sensing receptor.
    Shiohara M; Shiozawa R; Kurata K; Matsuura H; Arai F; Yasuda T; Koike K
    Endocr J; 2006 Dec; 53(6):797-802. PubMed ID: 16983178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia.
    Kinoshita Y; Hori M; Taguchi M; Watanabe S; Fukumoto S
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E363-8. PubMed ID: 24297799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report.
    Gonzales MC; Lieb DC; Richardson DW; O'Brian JT; Aloi JA; Khardori RK
    Endocr Pract; 2013; 19(1):e24-8. PubMed ID: 23186954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization.
    Misof BM; Roschger P; Dempster DW; Zhou H; Bilezikian JP; Klaushofer K; Rubin MR
    J Bone Miner Res; 2016 Jan; 31(1):180-9. PubMed ID: 26111772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
    Winer KK; Sinaii N; Reynolds J; Peterson D; Dowdy K; Cutler GB
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel activating mutation of human calcium-sensing receptor in a family with autosomal dominant hypocalcaemia.
    Baran N; ter Braak M; Saffrich R; Woelfle J; Schmitz U
    Mol Cell Endocrinol; 2015 May; 407():18-25. PubMed ID: 25766501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure.
    Gafni RI; Brahim JS; Andreopoulou P; Bhattacharyya N; Kelly MH; Brillante BA; Reynolds JC; Zhou H; Dempster DW; Collins MT
    J Bone Miner Res; 2012 Aug; 27(8):1811-20. PubMed ID: 22492501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium-sensing receptor and hypoparathyroidism].
    Michigami T
    Clin Calcium; 2007 Aug; 17(8):1186-91. PubMed ID: 17660614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders?
    Yamamoto M; Akatsu T; Nagase T; Ogata E
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4583-91. PubMed ID: 11134112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.
    Roszko KL; Stapleton Smith LM; Sridhar AV; Roberts MS; Hartley IR; Gafni RI; Collins MT; Fox JC; Nemeth EF
    J Bone Miner Res; 2022 Oct; 37(10):1926-1935. PubMed ID: 35879818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTH replacement therapy of hypoparathyroidism.
    Rejnmark L; Sikjaer T; Underbjerg L; Mosekilde L
    Osteoporos Int; 2013 May; 24(5):1529-36. PubMed ID: 23184178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired growth and intracranial calcifications in autosomal dominant hypocalcemia caused by a GNA11 mutation.
    Tenhola S; Voutilainen R; Reyes M; Toiviainen-Salo S; Jüppner H; Mäkitie O
    Eur J Endocrinol; 2016 Sep; 175(3):211-8. PubMed ID: 27334330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of hypoparathyroidism with intact parathyroid hormone.
    Rubin MR; Sliney J; McMahon DJ; Silverberg SJ; Bilezikian JP
    Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of hypoparathyroidism with PTH 1-34.
    Winer KK
    Bone; 2019 Mar; 120():535-541. PubMed ID: 30243992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety.
    Cusano NE; Rubin MR; McMahon DJ; Zhang C; Ives R; Tulley A; Sliney J; Cremers SC; Bilezikian JP
    J Clin Endocrinol Metab; 2013 Jan; 98(1):137-44. PubMed ID: 23162103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium.
    Winer KK; Ko CW; Reynolds JC; Dowdy K; Keil M; Peterson D; Gerber LH; McGarvey C; Cutler GB
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4214-20. PubMed ID: 12970289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.